Rare diseases
Investigational molecules
Locations
Back to Germany4 clinical trials in Gummersbach, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Investigating treatment outcomes in advanced breast cancer patients, with a focus on hormone receptor-positive HER2-negative cases in first-line therapy settings.
This comprehensive research examines spatial and temporal patterns in treatment efficacy, providing valuable insights into progression-free survival and overall survival rates in breast cancer patients.
Advanced research focusing on understanding treatment resistance patterns and therapeutic responses in breast cancer, incorporating sophisticated molecular analysis techniques.
The study aims to enhance our understanding of how advanced breast cancer responds to targeted therapies in first-line treatment scenarios.
Evaluating long-term treatment outcomes through comprehensive analysis of survival metrics in advanced breast cancer patients.
This research contributes to improving treatment strategies for hormone receptor-positive breast cancer patients through detailed analysis of clinical outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
